Age

6–11

Sex

ALL

Healthy volunteers

Not accepted

1. Participants aged 6 years to less than 12 years.
2. Documented medical history of migraine with or without aura for at least 6 months before the Screening Visit.
3. Weight \>15 kg at the Screening Visit

1. Evidence or history of clinically significant disease.
2. Continuous migraine (defined as an unrelenting headache) within 1 month prior to Screening Visit.
3. Atypical migraine types, complications of a migraine, or a confounding and clinically significant pain syndrome.
4. Conditions that may affect the administration or absorption of the nasal product
5. Any psychiatric condition that is uncontrolled and/or untreated, including:
* Clinically significant depression (Promis Parent Proxy SF 2.0 Depressive Scale T score ≥70)
* Suicidal ideation and behaviour (C-SSRS: any "yes" to items 2 to 5 or any "yes" to suicide behaviours)
6. Serum Total bilirubin \>1.5 × ULN (Upper Limit of Normal), AST (Aspartate Transferase) or ALT (Alanine Transaminase) \>2 × ULN
7. Abnormal ECG (Electrocardiogram) at screening visit

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine